A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD — Stella

Recruiting

Back to Heart Failure With Preserved Ejection Fraction trials

Trial locations(1 site)

United States

Mayo Clinic, Rochester, Minnesota

Key details

Sponsor

Mayo Clinic

Enrollment target

~25 participants

Started

October 2025

Primary completion

August 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov